 | • レポートコード：MRC2-11QY11234 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はがん検診/スクリーニングのグローバル市場について調査・分析したレポートです。種類別（肺がん、血液がん、骨がん、胆嚢がん、その他）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別がん検診/スクリーニングの競争状況、市場シェア ・世界のがん検診/スクリーニング市場：種類別市場規模 2015年-2020年（肺がん、血液がん、骨がん、胆嚢がん、その他） ・世界のがん検診/スクリーニング市場：種類別市場規模予測 2021年-2026年（肺がん、血液がん、骨がん、胆嚢がん、その他） ・世界のがん検診/スクリーニング市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界のがん検診/スクリーニング市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米のがん検診/スクリーニング市場分析：米国、カナダ ・ヨーロッパのがん検診/スクリーニング市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのがん検診/スクリーニング市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のがん検診/スクリーニング市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのがん検診/スクリーニング市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Dias Orin、Epigenetics、Techlab、Positive Bioscience、Genextropy、M Genomics、20/20 GeneSystems、AB SCIEX、Abbott Laboratories ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Screening means checking your body for cancer before you have symptoms.
In the recent years, Next Generation Sequencing (NGS) is being widely used for detection of various types of cancer.
Market Analysis and Insights: Global Cancer Testing/Screening Market
The global Cancer Testing/Screening market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cancer Testing/Screening Scope and Market Size
Cancer Testing/Screening market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Testing/Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Dias Orin
Epigenetics
Techlab
Positive Bioscience
Genextropy
M Genomics
20/20 GeneSystems
AB SCIEX
Abbott Laboratories
Market segment by Type, the product can be split into
Lung Cancer
Blood Cancer
Bone Cancer
Gall Bladder Cancer
Others
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cancer Testing/Screening Revenue
1.4 Market by Type
1.4.1 Global Cancer Testing/Screening Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Lung Cancer
1.4.3 Blood Cancer
1.4.4 Bone Cancer
1.4.5 Gall Bladder Cancer
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Testing/Screening Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cancer Testing/Screening Market Perspective (2015-2026)
2.2 Global Cancer Testing/Screening Growth Trends by Regions
2.2.1 Cancer Testing/Screening Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cancer Testing/Screening Historic Market Share by Regions (2015-2020)
2.2.3 Cancer Testing/Screening Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cancer Testing/Screening Market Growth Strategy
2.3.6 Primary Interviews with Key Cancer Testing/Screening Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cancer Testing/Screening Players by Market Size
3.1.1 Global Top Cancer Testing/Screening Players by Revenue (2015-2020)
3.1.2 Global Cancer Testing/Screening Revenue Market Share by Players (2015-2020)
3.1.3 Global Cancer Testing/Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cancer Testing/Screening Market Concentration Ratio
3.2.1 Global Cancer Testing/Screening Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cancer Testing/Screening Revenue in 2019
3.3 Cancer Testing/Screening Key Players Head office and Area Served
3.4 Key Players Cancer Testing/Screening Product Solution and Service
3.5 Date of Enter into Cancer Testing/Screening Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cancer Testing/Screening Historic Market Size by Type (2015-2020)
4.2 Global Cancer Testing/Screening Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cancer Testing/Screening Market Size by Application (2015-2020)
5.2 Global Cancer Testing/Screening Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cancer Testing/Screening Market Size (2015-2020)
6.2 Cancer Testing/Screening Key Players in North America (2019-2020)
6.3 North America Cancer Testing/Screening Market Size by Type (2015-2020)
6.4 North America Cancer Testing/Screening Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cancer Testing/Screening Market Size (2015-2020)
7.2 Cancer Testing/Screening Key Players in Europe (2019-2020)
7.3 Europe Cancer Testing/Screening Market Size by Type (2015-2020)
7.4 Europe Cancer Testing/Screening Market Size by Application (2015-2020)
8 China
8.1 China Cancer Testing/Screening Market Size (2015-2020)
8.2 Cancer Testing/Screening Key Players in China (2019-2020)
8.3 China Cancer Testing/Screening Market Size by Type (2015-2020)
8.4 China Cancer Testing/Screening Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cancer Testing/Screening Market Size (2015-2020)
9.2 Cancer Testing/Screening Key Players in Japan (2019-2020)
9.3 Japan Cancer Testing/Screening Market Size by Type (2015-2020)
9.4 Japan Cancer Testing/Screening Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cancer Testing/Screening Market Size (2015-2020)
10.2 Cancer Testing/Screening Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cancer Testing/Screening Market Size by Type (2015-2020)
10.4 Southeast Asia Cancer Testing/Screening Market Size by Application (2015-2020)
11 India
11.1 India Cancer Testing/Screening Market Size (2015-2020)
11.2 Cancer Testing/Screening Key Players in India (2019-2020)
11.3 India Cancer Testing/Screening Market Size by Type (2015-2020)
11.4 India Cancer Testing/Screening Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cancer Testing/Screening Market Size (2015-2020)
12.2 Cancer Testing/Screening Key Players in Central & South America (2019-2020)
12.3 Central & South America Cancer Testing/Screening Market Size by Type (2015-2020)
12.4 Central & South America Cancer Testing/Screening Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Dias Orin
13.1.1 Dias Orin Company Details
13.1.2 Dias Orin Business Overview
13.1.3 Dias Orin Cancer Testing/Screening Introduction
13.1.4 Dias Orin Revenue in Cancer Testing/Screening Business (2015-2020))
13.1.5 Dias Orin Recent Development
13.2 Epigenetics
13.2.1 Epigenetics Company Details
13.2.2 Epigenetics Business Overview
13.2.3 Epigenetics Cancer Testing/Screening Introduction
13.2.4 Epigenetics Revenue in Cancer Testing/Screening Business (2015-2020)
13.2.5 Epigenetics Recent Development
13.3 Techlab
13.3.1 Techlab Company Details
13.3.2 Techlab Business Overview
13.3.3 Techlab Cancer Testing/Screening Introduction
13.3.4 Techlab Revenue in Cancer Testing/Screening Business (2015-2020)
13.3.5 Techlab Recent Development
13.4 Positive Bioscience
13.4.1 Positive Bioscience Company Details
13.4.2 Positive Bioscience Business Overview
13.4.3 Positive Bioscience Cancer Testing/Screening Introduction
13.4.4 Positive Bioscience Revenue in Cancer Testing/Screening Business (2015-2020)
13.4.5 Positive Bioscience Recent Development
13.5 Genextropy
13.5.1 Genextropy Company Details
13.5.2 Genextropy Business Overview
13.5.3 Genextropy Cancer Testing/Screening Introduction
13.5.4 Genextropy Revenue in Cancer Testing/Screening Business (2015-2020)
13.5.5 Genextropy Recent Development
13.6 M Genomics
13.6.1 M Genomics Company Details
13.6.2 M Genomics Business Overview
13.6.3 M Genomics Cancer Testing/Screening Introduction
13.6.4 M Genomics Revenue in Cancer Testing/Screening Business (2015-2020)
13.6.5 M Genomics Recent Development
13.7 20/20 GeneSystems
13.7.1 20/20 GeneSystems Company Details
13.7.2 20/20 GeneSystems Business Overview
13.7.3 20/20 GeneSystems Cancer Testing/Screening Introduction
13.7.4 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2015-2020)
13.7.5 20/20 GeneSystems Recent Development
13.8 AB SCIEX
13.8.1 AB SCIEX Company Details
13.8.2 AB SCIEX Business Overview
13.8.3 AB SCIEX Cancer Testing/Screening Introduction
13.8.4 AB SCIEX Revenue in Cancer Testing/Screening Business (2015-2020)
13.8.5 AB SCIEX Recent Development
13.9 Abbott Laboratories
13.9.1 Abbott Laboratories Company Details
13.9.2 Abbott Laboratories Business Overview
13.9.3 Abbott Laboratories Cancer Testing/Screening Introduction
13.9.4 Abbott Laboratories Revenue in Cancer Testing/Screening Business (2015-2020)
13.9.5 Abbott Laboratories Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cancer Testing/Screening Key Market Segments
Table 2. Key Players Covered: Ranking by Cancer Testing/Screening Revenue
Table 3. Ranking of Global Top Cancer Testing/Screening Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cancer Testing/Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Lung Cancer
Table 6. Key Players of Blood Cancer
Table 7. Key Players of Bone Cancer
Table 8. Key Players of Gall Bladder Cancer
Table 9. Key Players of Others
Table 10. Global Cancer Testing/Screening Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Cancer Testing/Screening Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Cancer Testing/Screening Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Cancer Testing/Screening Market Share by Regions (2015-2020)
Table 14. Global Cancer Testing/Screening Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Cancer Testing/Screening Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Cancer Testing/Screening Market Growth Strategy
Table 20. Main Points Interviewed from Key Cancer Testing/Screening Players
Table 21. Global Cancer Testing/Screening Revenue by Players (2015-2020) (Million US$)
Table 22. Global Cancer Testing/Screening Market Share by Players (2015-2020)
Table 23. Global Top Cancer Testing/Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Testing/Screening as of 2019)
Table 24. Global Cancer Testing/Screening by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Cancer Testing/Screening Product Solution and Service
Table 27. Date of Enter into Cancer Testing/Screening Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 30. Global Cancer Testing/Screening Market Size Share by Type (2015-2020)
Table 31. Global Cancer Testing/Screening Revenue Market Share by Type (2021-2026)
Table 32. Global Cancer Testing/Screening Market Size Share by Application (2015-2020)
Table 33. Global Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 34. Global Cancer Testing/Screening Market Size Share by Application (2021-2026)
Table 35. North America Key Players Cancer Testing/Screening Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Cancer Testing/Screening Market Share (2019-2020)
Table 37. North America Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 38. North America Cancer Testing/Screening Market Share by Type (2015-2020)
Table 39. North America Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 40. North America Cancer Testing/Screening Market Share by Application (2015-2020)
Table 41. Europe Key Players Cancer Testing/Screening Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Cancer Testing/Screening Market Share (2019-2020)
Table 43. Europe Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Cancer Testing/Screening Market Share by Type (2015-2020)
Table 45. Europe Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Cancer Testing/Screening Market Share by Application (2015-2020)
Table 47. China Key Players Cancer Testing/Screening Revenue (2019-2020) (Million US$)
Table 48. China Key Players Cancer Testing/Screening Market Share (2019-2020)
Table 49. China Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 50. China Cancer Testing/Screening Market Share by Type (2015-2020)
Table 51. China Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 52. China Cancer Testing/Screening Market Share by Application (2015-2020)
Table 53. Japan Key Players Cancer Testing/Screening Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Cancer Testing/Screening Market Share (2019-2020)
Table 55. Japan Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Cancer Testing/Screening Market Share by Type (2015-2020)
Table 57. Japan Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Cancer Testing/Screening Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Cancer Testing/Screening Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Cancer Testing/Screening Market Share (2019-2020)
Table 61. Southeast Asia Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Cancer Testing/Screening Market Share by Type (2015-2020)
Table 63. Southeast Asia Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Cancer Testing/Screening Market Share by Application (2015-2020)
Table 65. India Key Players Cancer Testing/Screening Revenue (2019-2020) (Million US$)
Table 66. India Key Players Cancer Testing/Screening Market Share (2019-2020)
Table 67. India Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 68. India Cancer Testing/Screening Market Share by Type (2015-2020)
Table 69. India Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 70. India Cancer Testing/Screening Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Cancer Testing/Screening Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Cancer Testing/Screening Market Share (2019-2020)
Table 73. Central & South America Cancer Testing/Screening Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Cancer Testing/Screening Market Share by Type (2015-2020)
Table 75. Central & South America Cancer Testing/Screening Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Cancer Testing/Screening Market Share by Application (2015-2020)
Table 77. Dias Orin Company Details
Table 78. Dias Orin Business Overview
Table 79. Dias Orin Product
Table 80. Dias Orin Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 81. Dias Orin Recent Development
Table 82. Epigenetics Company Details
Table 83. Epigenetics Business Overview
Table 84. Epigenetics Product
Table 85. Epigenetics Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 86. Epigenetics Recent Development
Table 87. Techlab Company Details
Table 88. Techlab Business Overview
Table 89. Techlab Product
Table 90. Techlab Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 91. Techlab Recent Development
Table 92. Positive Bioscience Company Details
Table 93. Positive Bioscience Business Overview
Table 94. Positive Bioscience Product
Table 95. Positive Bioscience Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 96. Positive Bioscience Recent Development
Table 97. Genextropy Company Details
Table 98. Genextropy Business Overview
Table 99. Genextropy Product
Table 100. Genextropy Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 101. Genextropy Recent Development
Table 102. M Genomics Company Details
Table 103. M Genomics Business Overview
Table 104. M Genomics Product
Table 105. M Genomics Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 106. M Genomics Recent Development
Table 107. 20/20 GeneSystems Company Details
Table 108. 20/20 GeneSystems Business Overview
Table 109. 20/20 GeneSystems Product
Table 110. 20/20 GeneSystems Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 111. 20/20 GeneSystems Recent Development
Table 112. AB SCIEX Business Overview
Table 113. AB SCIEX Product
Table 114. AB SCIEX Company Details
Table 115. AB SCIEX Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 116. AB SCIEX Recent Development
Table 117. Abbott Laboratories Company Details
Table 118. Abbott Laboratories Business Overview
Table 119. Abbott Laboratories Product
Table 120. Abbott Laboratories Revenue in Cancer Testing/Screening Business (2015-2020) (Million US$)
Table 121. Abbott Laboratories Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Testing/Screening Market Share by Type: 2020 VS 2026
Figure 2. Lung Cancer Features
Figure 3. Blood Cancer Features
Figure 4. Bone Cancer Features
Figure 5. Gall Bladder Cancer Features
Figure 6. Others Features
Figure 7. Global Cancer Testing/Screening Market Share by Application: 2020 VS 2026
Figure 8. Hospitals and Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Cancer Testing/Screening Report Years Considered
Figure 11. Global Cancer Testing/Screening Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cancer Testing/Screening Market Share by Regions: 2020 VS 2026
Figure 13. Global Cancer Testing/Screening Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cancer Testing/Screening Market Share by Players in 2019
Figure 16. Global Top Cancer Testing/Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Testing/Screening as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cancer Testing/Screening Revenue in 2019
Figure 18. North America Cancer Testing/Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cancer Testing/Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cancer Testing/Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cancer Testing/Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cancer Testing/Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cancer Testing/Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cancer Testing/Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
子宮頸がんスクリーニングの世界市場（～2026年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…- 子宮がん診断検査の世界市場（～2026年） Uterus a female organ also referred as the womb is located in the lower abdomen. It supports in the fetal development until birth. In North America, the U.S. is expected to be the dominant market for uterine cancer diagnostic testing due to growing incidence of uterine cancer. Market Analysis and In…
- 乳癌スクリーニング検査の世界市場（～2026年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…
- 前立腺がんスクリーニングの世界市場（～2026年） Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms. The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measu…
- 遺伝性がん検査の世界市場（～2026年） Hereditary cancer testing is a process of identifying an inherited gene mutation that increases the risk of cancer development. It mainly includes predictive genetic testing and clinical DNA sequencing, in predictive genetic testing, patient’s family history is analyzed for any inherited mutation fr…